|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Makkonen M, Bertling E, Chebotareva NA,
Baum J and Lappalainen P: Mammalian and malaria parasite
cyclase-associated proteins catalyze nucleotide exchange on G-actin
through a conserved mechanism. J Biol Chem. 288:984–994. 2013.
View Article : Google Scholar :
|
|
3
|
Fedor-Chaiken M, Deschenes RJ and Broach
JR: SRV2, a gene required for RAS activation of adenylate cyclase
in yeast. Cell. 61:329–340. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Olson MF and Sahai E: The actin
cytoskeleton in cancer cell motility. Clin Exp Metastasis.
26:273–287. 2009. View Article : Google Scholar
|
|
5
|
Yilmaz M and Christofori G: EMT, the
cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev.
28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peche V, Shekar S, Leichter M, Korte H,
Schröder R, Schleicher M, Holak TA, Clemen CS, Ramanath-Y B,
Pfitzer G, et al: CAP2, cyclase-associated protein 2, is a dual
compartment protein. Cell Mol Life Sci. 64:2702–2715. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liu Y, Cui X, Hu B, Lu C, Huang X, Cai J,
He S, Lv L, Cong X, Liu G, et al: Upregulated expression of CAP1 is
associated with tumor migration and metastasis in hepatocellular
carcinoma. Pathol Res Pract. 210:169–175. 2014. View Article : Google Scholar
|
|
8
|
Yu XF, Ni QC, Chen JP, Xu JF, Jiang Y,
Yang SY, Ma J, Gu XL, Wang H and Wang YY: Knocking down the
expression of adenylate cyclase-associated protein 1 inhibits the
proliferation and migration of breast cancer cells. Exp Mol Pathol.
96:188–194. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hua M, Yan S, Deng Y, Xi Q, Liu R, Yang S,
Liu J, Tang C, Wang Y and Zhong J: CAP1 is overexpressed in human
epithelial ovarian cancer and promotes cell proliferation. Int J
Mol Med. 35:941–949. 2015.PubMed/NCBI
|
|
10
|
Shibata R, Mori T, Du W, Chuma M, Gotoh M,
Shimazu M, Ueda M, Hirohashi S and Sakamoto M: Overexpression of
cyclase-associated protein 2 in multistage hepatocarcinogenesis.
Clin Cancer Res. 12:5363–5368. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Masugi Y, Tanese K, Emoto K, Yamazaki K,
Effendi K, Funakoshi T, Mori M and Sakamoto M: Overexpression of
adenylate cyclase-associated protein 2 is a novel prognostic marker
in malignant melanoma. Pathol Int. 65:627–634. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Song LB, Zeng MS, Liao WT, Zhang L, Mo HY,
Liu WL, Shao JY, Wu QL, Li MZ, Xia YF, et al: Bmi-1 is a novel
molecular marker of nasopharyngeal carcinoma progression and
immortalizes primary human nasopharyngeal epithelial cells. Cancer
Res. 66:6225–6232. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ono S: The role of cyclase-associated
protein in regulating actin filament dynamics - more than a
monomer-sequestration factor. J Cell Sci. 126:3249–3258. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bertling E, Hotulainen P, Mattila PK,
Matilainen T, Salminen M and Lappalainen P: Cyclase-associated
protein 1 (CAP1) promotes cofilin-induced actin dynamics in
mammalian nonmuscle cells. Mol Biol Cell. 15:2324–2334. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yamazaki K, Takamura M, Masugi Y, Mori T,
Du W, Hibi T, Hiraoka N, Ohta T, Ohki M, Hirohashi S, et al:
Adenylate cyclase-associated protein 1 overexpressed in pancreatic
cancers is involved in cancer cell motility. Lab Invest.
89:425–432. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li M, Yang X, Shi H, Ren H, Chen X, Zhang
S, Zhu J and Zhang J: Downregulated expression of the
cyclase-associated protein 1 (CAP1) reduces migration in esophageal
squamous cell carcinoma. Jpn J Clin Oncol. 43:856–864. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xie SS, Tan M, Lin HY, Xu L, Shen CX, Yuan
Q, Song XL and Wang CH: Overexpression of adenylate
cyclase-associated protein 1 may predict brain metastasis in
non-small cell lung cancer. Oncol Rep. 33:363–371. 2015.
|
|
18
|
Effendi K, Yamazaki K, Mori T, Masugi Y,
Makino S and Sakamoto M: Involvement of hepatocellular carcinoma
biomarker, cyclase-associated protein 2 in zebrafish body
development and cancer progression. Exp Cell Res. 319:35–44. 2013.
View Article : Google Scholar
|
|
19
|
Kirfel G, Rigort A, Borm B and Herzog V:
Cell migration: Mechanisms of rear detachment and the formation of
migration tracks. Eur J Cell Biol. 83:717–724. 2004. View Article : Google Scholar
|
|
20
|
Zhou GL, Zhang H and Field J: Mammalian
CAP (Cyclase-associated protein) in the world of cell migration:
Roles in actin filament dynamics and beyond. Cell Adhes Migr.
8:55–59. 2014. View Article : Google Scholar
|
|
21
|
Fu J, Li M, Wu DC, Liu LL, Chen SL and Yun
JP: Increased expression of CAP2 indicates poor prognosis in
hepatocellular carcinoma. Transl Oncol. 8:400–406. 2015. View Article : Google Scholar : PubMed/NCBI
|
